» Articles » PMID: 33374230

An In Vitro Cell Culture Model for Pyoverdine-Mediated Virulence

Overview
Journal Pathogens
Date 2020 Dec 30
PMID 33374230
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

is a multidrug-resistant, opportunistic pathogen that utilizes a wide-range of virulence factors to cause acute, life-threatening infections in immunocompromised patients, especially those in intensive care units. It also causes debilitating chronic infections that shorten lives and worsen the quality of life for cystic fibrosis patients. One of the key virulence factors in is the siderophore pyoverdine, which provides the pathogen with iron during infection, regulates the production of secreted toxins, and disrupts host iron and mitochondrial homeostasis. These roles have been characterized in model organisms such as and mice. However, an intermediary system, using cell culture to investigate the activity of this siderophore has been absent. In this report, we describe such a system, using murine macrophages treated with pyoverdine. We demonstrate that pyoverdine-rich filtrates from exhibit substantial cytotoxicity, and that the inhibition of pyoverdine production (genetic or chemical) is sufficient to mitigate virulence. Furthermore, consistent with previous observations made in , pyoverdine translocates into cells and disrupts host mitochondrial homeostasis. Most importantly, we observe a strong correlation between pyoverdine production and virulence in clinical isolates, confirming pyoverdine's value as a promising target for therapeutic intervention. This in vitro cell culture model will allow rapid validation of pyoverdine antivirulents in a simple but physiologically relevant manner.

Citing Articles

Establishment and characterization of persistent infections in air-liquid interface cultures of human airway epithelial cells.

Bouheraoua S, Cleeves S, Preusse M, Musken M, Braubach P, Fuchs M Infect Immun. 2025; 93(3):e0060324.

PMID: 39964154 PMC: 11895474. DOI: 10.1128/iai.00603-24.


Antimicrobial activity of iron-depriving pyoverdines against human opportunistic pathogens.

Vollenweider V, Rehm K, Chepkirui C, Perez-Berlanga M, Polymenidou M, Piel J Elife. 2024; 13.

PMID: 39693130 PMC: 11655065. DOI: 10.7554/eLife.92493.


A Fully-Printed Wearable Bandage-Based Electrochemical Sensor with pH Correction for Wound Infection Monitoring.

Kaewpradub K, Veenuttranon K, Jantapaso H, Mittraparp-Arthorn P, Jeerapan I Nanomicro Lett. 2024; 17(1):71.

PMID: 39589694 PMC: 11599554. DOI: 10.1007/s40820-024-01561-8.


Cytotoxic rhamnolipid micelles drive acute virulence in .

Xu Q, Kang D, Meyer M, Pennington C, Gopal C, Schertzer J Infect Immun. 2024; 92(3):e0040723.

PMID: 38391248 PMC: 10929412. DOI: 10.1128/iai.00407-23.


lung epithelial cell model reveals novel roles for siderophores.

Kang D, Xu Q, Kirienko N Microbiol Spectr. 2024; 12(3):e0369323.

PMID: 38311809 PMC: 10913452. DOI: 10.1128/spectrum.03693-23.


References
1.
Kang D, Kirienko D, Webster P, Fisher A, Kirienko N . Pyoverdine, a siderophore from Pseudomonas aeruginosa, translocates into C. elegans, removes iron, and activates a distinct host response. Virulence. 2018; 9(1):804-817. PMC: 5955448. DOI: 10.1080/21505594.2018.1449508. View

2.
Meyer J, Neely A, Stintzi A, Georges C, Holder I . Pyoverdin is essential for virulence of Pseudomonas aeruginosa. Infect Immun. 1996; 64(2):518-23. PMC: 173795. DOI: 10.1128/iai.64.2.518-523.1996. View

3.
Malloy J, Veldhuizen R, Thibodeaux B, OCallaghan R, Wright J . Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am J Physiol Lung Cell Mol Physiol. 2004; 288(2):L409-18. DOI: 10.1152/ajplung.00322.2004. View

4.
Aiello D, Williams J, Majgier-Baranowska H, Patel I, Peet N, Huang J . Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion. Antimicrob Agents Chemother. 2010; 54(5):1988-99. PMC: 2863679. DOI: 10.1128/AAC.01598-09. View

5.
Weigert M, Ross-Gillespie A, Leinweber A, Pessi G, Brown S, Kummerli R . Manipulating virulence factor availability can have complex consequences for infections. Evol Appl. 2016; 10(1):91-101. PMC: 5192820. DOI: 10.1111/eva.12431. View